Literature DB >> 11035131

Circulating collagen metabolites in systemic sclerosis. Differences between limited and diffuse form and relationship with pulmonary involvement.

A Scheja1, M Wildt, F A Wollheim, A Akesson, T Saxne.   

Abstract

OBJECTIVE: To study collagen metabolites in systemic sclerosis (SSc) and their relationship with clinical manifestations of the disease.
METHODS: Forty-eight SSc patients, 13 with a diffuse form (dcSSc), 23 with a limited form (lcSSc) and 12 with suspected SSc not fulfilling the ACR criteria, and 31 healthy controls were examined. Serum concentrations of aminoterminal type III procollagen peptide (PIIINP), aminoterminal and carboxyterminal type I procollagen peptides (PINP and PICP) and cross-linked carboxyterminal telopeptide of collagen I (ICTP) were determined by radioimmunoassay.
RESULTS: Increased serum concentrations of ICTP were found in SSc patients compared with controls. Distinctly higher levels of ICTP were observed in dcSSc than in lcSSc. High serum ICTP was correlated with skin score and acute phase reactants, and with reduced pulmonary function. Serum PIIINP concentration was elevated in both lcSSc and dcSSc.
CONCLUSION: Augmented collagen catabolism accompanies the increased collagen synthesis in SSc. Serum ICTP concentration is a marker of this feature and also reflects clinical severity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11035131     DOI: 10.1093/rheumatology/39.10.1110

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  13 in total

Review 1.  [Laboratory diagnostics for systemic sclerosis].

Authors:  R Mierau; A Roers; E Genth
Journal:  Z Rheumatol       Date:  2007-05       Impact factor: 1.372

Review 2.  [Current pathophysiological aspects of systemic sclerosis].

Authors:  T Krieg; N Hunzelmann
Journal:  Z Rheumatol       Date:  2006-07       Impact factor: 1.372

Review 3.  The current state of biomarkers in systemic sclerosis.

Authors:  Laura K Hummers
Journal:  Curr Rheumatol Rep       Date:  2010-02       Impact factor: 4.592

4.  A four-gene biomarker predicts skin disease in patients with diffuse cutaneous systemic sclerosis.

Authors:  G Farina; D Lafyatis; R Lemaire; R Lafyatis
Journal:  Arthritis Rheum       Date:  2010-02

5.  Serum concentrations of aminoterminal propeptide of type III procollagen and propeptide of human type I procollagen in systemic lupus erythematosus.

Authors:  A I Villa-Manzano; J I Gamez-Nava; M Salazar-Paramo; I C Valera-Gonzalez; A Garcia-Gonzalez; G Garcia-Gonzalez; J Morales-Romero; A Lopez-Olivo; L M Galvan-Ramirez; R Ruiz-Ruvalcaba; E G Cardona-Muñoz; L Gonzalez-Lopez
Journal:  Rheumatol Int       Date:  2005-10-18       Impact factor: 2.631

Review 6.  Interstitial lung disease in systemic sclerosis.

Authors:  Predrag Ostojic; Marco Matucci Cerinic; Richard Silver; Kristin Highland; Nemanja Damjanov
Journal:  Lung       Date:  2007 Jul-Aug       Impact factor: 2.584

7.  Urinary procollagen III aminoterminal propeptide (PIIINP): a fibrotest for the nephrologist.

Authors:  Balsam El Ghoul; Tarek Squalli; Aude Servais; Caroline Elie; Vannary Meas-Yedid; Christine Trivint; Jill Vanmassenhove; Jean-Pierre Grünfeld; Jean-Christophe Olivo-Marin; Eric Thervet; Laure-Hélène Noël; Dominique Prié; Fadi Fakhouri
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-14       Impact factor: 8.237

8.  Procollagen type I N-terminal propeptide (PINP) is a marker for fibrogenesis in bile duct ligation-induced fibrosis in rats.

Authors:  Sanne Skovgård Veidal; Efstathios Vassiliadis; Anne-Christine Bay-Jensen; Gervais Tougas; Ben Vainer; Morten Asser Karsdal
Journal:  Fibrogenesis Tissue Repair       Date:  2010-04-01

9.  Skin autofluorescence, as marker of accumulation of advanced glycation endproducts and of cumulative metabolic stress, is not increased in patients with systemic sclerosis.

Authors:  M E Hettema; H Bootsma; R Graaff; R de Vries; C G M Kallenberg; A J Smit
Journal:  Int J Rheumatol       Date:  2011-09-29

10.  Paclitaxel modulates TGFbeta signaling in scleroderma skin grafts in immunodeficient mice.

Authors:  Xialin Liu; Shoukang Zhu; Tao Wang; Laura Hummers; Fredrick M Wigley; Pascal J Goldschmidt-Clermont; Chunming Dong
Journal:  PLoS Med       Date:  2005-11-01       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.